Aeterna Zentaris
AEZS
#10364
Rank
NZ$29.92 M
Marketcap
NZ$9.78
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.50. In 2022 the company made an earnings per share (EPS) of NZ-$8.00 a decrease over its 2021 EPS that were of NZ-$3.11.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$8.00157.14%
2021NZ-$3.11-41.48%
2020NZ-$5.31-64.46%
2019NZ-$14.95-240%
2018NZ$10.68-122.32%
2017NZ-$47.85-53.53%
2016NZ-$102.97-86.71%
2015NZ-$775.03-35.21%
2014NZ-$1,196-216.67%
2013NZ$1,025-123.3%
2012NZ-$4,401-40.8%
2011NZ-$7,434-6.45%
2010NZ-$7,947-27.91%
2009NZ-$11,023-61.61%
2008NZ-$28,71183.61%
2007NZ-$15,637-195.31%
2006NZ$16,406178.26%
2005NZ$5,896-330%
2004NZ-$2,563-80.05%
2003NZ-$12,84917.78%
2002NZ-$10,910515.93%
2001NZ-$1,771-68.6%
2000NZ-$5,642119.62%
1999NZ-$2,569-3.63%
1998NZ-$2,666

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.00-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$4.37-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.08-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.46-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA